Drawing for EMPRANDO

USPTO serial 79405416

EMPRANDO

Reviewed by CopyMark Law Group

Reg. 7910272Status 700Registered
Filing date
Status date
Registration date
Aug 26, 2025
Examiner
CORNWELL, ANDREA B
Law office
FILE REPOSITORY (FRANCONIA)

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EMPRANDO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Maury M. Tepper, III

Maury M. Tepper, III Tepper & Eyster, PLLC3724 Benson DriveRaleigh, NC 27609United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical and medical preparations and medical injection devices for administering drugs sold pre-filled with pharmaceutical preparations, all for the prevention and treatment of renal diseases and disorders, inflammatory diseases and disorders, dermatological diseases and disorders, gastrointestinal diseases and disorders, respiratory diseases and disorders, complement-mediated diseases and disorders, neoplastic diseases and disorders, bone diseases and disorders, diseases and disorders of the immune system, the cardiovascular system, the musculo-skeletal system, the genitourinary system, the central nervous system, the endocrine system, the metabolic system and the circulatory systemACTIVE—
010Medical injection devices for the administration of pharmaceutical preparationsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 2, 2026FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Mar 26, 2026OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Mar 13, 2026FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 13, 2026FIMPFINAL DISPOSITION PROCESSED—
Feb 25, 2026OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 25, 2026OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Nov 26, 2025FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Aug 26, 2025NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Aug 26, 2025R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 8, 2025NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jul 8, 2025PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jul 2, 2025NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jun 5, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jun 2, 2025TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jun 2, 2025CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jun 2, 2025TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 12, 2025RFNTREFUSAL PROCESSED BY IB—
Mar 20, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Mar 20, 2025RFRRREFUSAL PROCESSED BY MPU—
Mar 13, 2025RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Mar 12, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 11, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 28, 2025RFWRNON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW—
Jan 14, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 13, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 13, 2025ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jan 13, 2025CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 6, 2025DOCKASSIGNED TO EXAMINER—
Nov 6, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Nov 6, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 6, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 6, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Nov 6, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 15, 2024MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 15, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 27, 2024LIMILIMITATION FROM ORIGINAL APPLICATION ENTERED—
Sep 26, 2024SDRCSN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB—

Frequently asked questions

Related guidance